136 related articles for article (PubMed ID: 26623041)
1. Diagnostic value of cyclin-dependent kinase/cyclin-dependent kinase inhibitor expression ratios as biomarkers of locoregional and hematogenous dissemination risks in oral squamous cell carcinoma.
Nagata M; Kurita H; Uematsu K; Ogawa S; Takahashi K; Hoshina H; Takagi R
Mol Clin Oncol; 2015 Sep; 3(5):1007-1013. PubMed ID: 26623041
[TBL] [Abstract][Full Text] [Related]
2. ITGA3 and ITGB4 expression biomarkers estimate the risks of locoregional and hematogenous dissemination of oral squamous cell carcinoma.
Nagata M; Noman AA; Suzuki K; Kurita H; Ohnishi M; Ohyama T; Kitamura N; Kobayashi T; Uematsu K; Takahashi K; Kodama N; Kawase T; Hoshina H; Ikeda N; Shingaki S; Takagi R
BMC Cancer; 2013 Sep; 13():410. PubMed ID: 24006899
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic value of integrin alpha3, beta4, and beta5 gene expression levels for the clinical outcome of tongue squamous cell carcinoma.
Kurokawa A; Nagata M; Kitamura N; Noman AA; Ohnishi M; Ohyama T; Kobayashi T; Shingaki S; Takagi R;
Cancer; 2008 Mar; 112(6):1272-81. PubMed ID: 18224668
[TBL] [Abstract][Full Text] [Related]
4. Tetraspanin gene expression levels as potential biomarkers for malignancy of gingival squamous cell carcinoma.
Hirano C; Nagata M; Noman AA; Kitamura N; Ohnishi M; Ohyama T; Kobayashi T; Suzuki K; Yoshizawa M; Izumi N; Fujita H; Takagi R
Int J Cancer; 2009 Jun; 124(12):2911-6. PubMed ID: 19330835
[TBL] [Abstract][Full Text] [Related]
5. The gene ratios c-MYC:cyclin-dependent kinase (CDK)N2A and CCND1:CDKN2A correlate with poor prognosis in squamous cell carcinoma of the head and neck.
Akervall J; Bockmühl U; Petersen I; Yang K; Carey TE; Kurnit DM
Clin Cancer Res; 2003 May; 9(5):1750-5. PubMed ID: 12738730
[TBL] [Abstract][Full Text] [Related]
6. Semaphorin7A Promotion of Tumoral Growth and Metastasis in Human Oral Cancer by Regulation of G1 Cell Cycle and Matrix Metalloproteases: Possible Contribution to Tumoral Angiogenesis.
Saito T; Kasamatsu A; Ogawara K; Miyamoto I; Saito K; Iyoda M; Suzuki T; Endo-Sakamoto Y; Shiiba M; Tanzawa H; Uzawa K
PLoS One; 2015; 10(9):e0137923. PubMed ID: 26378920
[TBL] [Abstract][Full Text] [Related]
7. Evaluation of the mRNA expression levels of integrins α3, α5, β1 and β6 as tumor biomarkers of oral squamous cell carcinoma.
Chang HW; Yen CY; Chen CH; Tsai JH; Tang JY; Chang YT; Kao YH; Wang YY; Yuan SF; Lee SY
Oncol Lett; 2018 Oct; 16(4):4773-4781. PubMed ID: 30214610
[TBL] [Abstract][Full Text] [Related]
8. Kip/Cip and Ink4 Cdk inhibitors cooperate to induce cell cycle arrest in response to TGF-beta.
Reynisdóttir I; Polyak K; Iavarone A; Massagué J
Genes Dev; 1995 Aug; 9(15):1831-45. PubMed ID: 7649471
[TBL] [Abstract][Full Text] [Related]
9. A correlation of immunohistochemical expression of
Pandya JA; Boaz K; Natarajan S; Manaktala N; Nandita KP; Lewis AJ
J Cancer Res Ther; 2018; 14(3):666-670. PubMed ID: 29893337
[TBL] [Abstract][Full Text] [Related]
10. Identification of a Favorable Prognostic Subgroup in Oral Squamous Cell Carcinoma: Characterization of ITGB4/PD-L1
Ma SR; Liu JF; Jia R; Deng WW; Jia J
Biomolecules; 2023 Jun; 13(6):. PubMed ID: 37371594
[TBL] [Abstract][Full Text] [Related]
11. Psoriatic epidermis is associated with upregulation of CDK2 and inhibition of CDK4 activity.
Henri P; Prevel C; Pellerano M; Lacotte J; Stoebner PE; Morris MC; Meunier L
Br J Dermatol; 2020 Mar; 182(3):678-689. PubMed ID: 31145809
[TBL] [Abstract][Full Text] [Related]
12. Cyclin D2 overexpression and lack of p27 correlate positively and cyclin E inversely with a poor prognosis in gastric cancer cases.
Takano Y; Kato Y; van Diest PJ; Masuda M; Mitomi H; Okayasu I
Am J Pathol; 2000 Feb; 156(2):585-94. PubMed ID: 10666388
[TBL] [Abstract][Full Text] [Related]
13. High integrin α3 expression is associated with poor prognosis in patients with non-small cell lung cancer.
Li Q; Ma W; Chen S; Tian EC; Wei S; Fan RR; Wang T; Zhou C; Li T
Transl Lung Cancer Res; 2020 Aug; 9(4):1361-1378. PubMed ID: 32953510
[TBL] [Abstract][Full Text] [Related]
14. CDKN2A, CDK1, and CCNE1 overexpression in sebaceous gland carcinoma of eyelid.
Yunoki T; Hirano T; Tabuchi Y; Furusawa Y; Torigoe M; Nakajima T; Imura J; Hayashi A
Int Ophthalmol; 2020 Feb; 40(2):343-350. PubMed ID: 31571090
[TBL] [Abstract][Full Text] [Related]
15. Candidate gene analysis using imputed genotypes: cell cycle single-nucleotide polymorphisms and ovarian cancer risk.
Goode EL; Fridley BL; Vierkant RA; Cunningham JM; Phelan CM; Anderson S; Rider DN; White KL; Pankratz VS; Song H; Hogdall E; Kjaer SK; Whittemore AS; DiCioccio R; Ramus SJ; Gayther SA; Schildkraut JM; Pharaoh PP; Sellers TA
Cancer Epidemiol Biomarkers Prev; 2009 Mar; 18(3):935-44. PubMed ID: 19258477
[TBL] [Abstract][Full Text] [Related]
16. Differences in the Conformational Energy Landscape of CDK1 and CDK2 Suggest a Mechanism for Achieving Selective CDK Inhibition.
Wood DJ; Korolchuk S; Tatum NJ; Wang LZ; Endicott JA; Noble MEM; Martin MP
Cell Chem Biol; 2019 Jan; 26(1):121-130.e5. PubMed ID: 30472117
[TBL] [Abstract][Full Text] [Related]
17. CDK1 and CDK2 activity is a strong predictor of renal cell carcinoma recurrence.
Hongo F; Takaha N; Oishi M; Ueda T; Nakamura T; Naitoh Y; Naya Y; Kamoi K; Okihara K; Matsushima T; Nakayama S; Ishihara H; Sakai T; Miki T
Urol Oncol; 2014 Nov; 32(8):1240-6. PubMed ID: 25443276
[TBL] [Abstract][Full Text] [Related]
18. Induced expression of p16(INK4a) inhibits both CDK4- and CDK2-associated kinase activity by reassortment of cyclin-CDK-inhibitor complexes.
McConnell BB; Gregory FJ; Stott FJ; Hara E; Peters G
Mol Cell Biol; 1999 Mar; 19(3):1981-9. PubMed ID: 10022885
[TBL] [Abstract][Full Text] [Related]
19. Role of Genetic Variations in
Híveš M; Jurečeková J; Kliment J; Grendár M; Kaplán P; Dušenka R; Evin D; Vilčková M; Holečková KH; Sivoňová MK
Cancer Genomics Proteomics; 2022; 19(3):362-371. PubMed ID: 35430569
[TBL] [Abstract][Full Text] [Related]
20. Targeting cyclin-dependent kinase 1 (CDK1) but not CDK4/6 or CDK2 is selectively lethal to MYC-dependent human breast cancer cells.
Kang J; Sergio CM; Sutherland RL; Musgrove EA
BMC Cancer; 2014 Jan; 14():32. PubMed ID: 24444383
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]